Sodium bicarbonate, also known as baking soda, has been shown to have significant anti-cancer properties when administered intravenously. Research has demonstrated that sodium bicarbonate can induce programmed cell death (apoptosis) in cancer cells, as well as inhibit the growth and spread of cancer cells. Sodium bicarbonate has been shown to be effective in treating a variety of cancers, including breast, prostate, and lung cancer, by interfering with multiple cellular signaling pathways involved in cancer development and progression.